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1. Introduction
Research has opened up a 
huge potential for developing 
ways to correct and manage the 
hair growth cycle with biologi-
cally active substances, growth 
factors and hormones, and has 
actually revolutionized this. The 
aggressive effect of androgens 
on the hair follicle in the an-
drogen-dependent areas of the 
scalp is considered as the main 
etiopathogenetic mechanism 
of AGA [1, 2]. However, recent 
scientific data show that oxida-
tive stress, microinflammation, 
apoptosis and fibrosis can be con-
sidered as non-androgenic cofac-
tors of its development [3, 4]. The 
targeted treatment, that must 
show effect on each link in the 
pathogenesis of AGA, is likely to 
lead to a more long-lasting and 
greater therapeutic result and to 
complete existing treatment reg-
imens for this pathology.
Great therapeutic potential 
involves the use of autologous 
plasma, enriched with plate-
lets, as a method that indirect-
ly stimulates the cells of the 
dermal papilla [5]. The dermal 
papilla and connective tissue are 
formed from the same progen-
itor cells as the fibroblasts in 
the interfollicular dermis, but 
their gene expression profile and 
biological functions are radical-
ly different [6]. If interfollicular 
fibroblasts promote the growth 
and differentiation of upper ep-
ithelial cells (keratinocytes), the 
dermal papilla and connective 
tissue play a major role in reg-
ulating hair growth. The method is based on the concept 
of platelet-enriched plasma as a natural source of signalling 
molecules that have a paracrine effect on other cells. The 
main functions of platelets in the repair of damaged tissue are 
modulation of inflammation through the interaction of innate 
immune cells, regulation of angiogenesis and stimulation of 
cell migration and proliferation [7].
Taking into account the molecular-biological control ele-
ments of the system of physiological degeneration of the hair 
follicle, the effectiveness of the use of platelet-rich plasma in 
AGA has not been established yet.
The aim of the research was to study the immunohisto-
chemical (IHC) characteristics of the skin in women with AGA 
before and after treatment with platelet-rich plasma in combina-
tion with topical minoxidil 2 %.
2. Materials and methods
Female patients with AGA I-II according to Ludwig scale 
were included in the study after signing the informed con-
sent.
The material for the study 
were scalp biopsies of 30 women 
with AGA aged 22 to 40 years 
(mean age 32.1 years) who were 
monitored in the period from 
2017 to 2020 at the clinical base 
of the Department of Infectious 
Diseases and Clinical Immunol-
ogy of the Medical Faculty of 
V. N. Karazin Kharkiv National 
University – “Trichology Institu- 
te”. Patients received injections 
of platelet-rich plasma in combi- 
nation with topical minoxidil 
2 % lotion.
In the control group there 
were 20 skin samples of women 
without signs of AGA and other 
diseases aged 25–40 years (mean 
age 34.7 years), who underwent 
autopsies in the pathology de-
partment of Clinical city hospital 
No. 17 in Kharkiv.
During the study, the provi-
sions of the Helsinki Declaration 
of the World Medical Associa-
tion, the ethical code of the doc-
tor of Ukraine and informing 
the patient about the nature of 
the study were strictly observed. 
All patients involved in the study 
signed informed consent to par-
ticipate in the study. Protocol 
No. 2 of the Commission on Bio-
medical Ethics of V. N. Karaz-
in Kharkiv National Universi-
ty of the Ministry of Science of 
Ukraine dated 13.05.2021.
Topically, patients used Mi-
noxidil Inteli 2 % dermal solution 
60 ml, manufacturer: Indastrial 
Farm. Cantabria (Spain), registra-
tion certificate: UA/14771/01/02, 
Inteli Generics Nord (Lithuania). 
Applied every morning and evening to androgen-dependent 
areas of the scalp (frontal and parietal), kept the exposure for at 
least 4 hours.
RegenBCT kits (Regenlab PRP Kit-RegenACR®, Le Mont- 
sur-Lausanne Switzerland) were used for PRP preparations and 
further injections. From 8 ml of blood by a single centrifugation 
for 5 minutes received 4-5 ml of plasma, in which the concentra-
tion of platelets was ×1.6 from the initial.
Injections were performed into the thinning areas of the 
hair in the technique of injection-by-injection with a 30G 
needle. At each injection, approximately 0.15–0.20 ml of the 
obtained PRP was administered. The distance between the in-
jection points was 0.5–1 cm. Patients were advised not to wash 
his head for 4 hours after the procedure.
The biopsy was taken from the center of the hair loss area. 
The technique consisted of making deep cylindrical incisions 
covering all layers of the skin, using a 4-mm punch. 1 punch 
biopsy with a diameter of 4 mm was taken. Vertical and hori-
zontal (transverse) sections were made from one biopsy, which 
was divided into two parts by a vertical section.
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Abstract: The aim. The research was provided to obtain 
immunohistochemical changes in scalp biopsies of female 
patients with androgenetic alopecia (AGA) I-II stages ac-
cording to the Ludwig scale and to detect possible changes 
after usage of platelet-rich plasma (PRP) injections in com-
bination with topical minoxidil 2 % lotion. 
Materials and methods. Skin biopsies of 30 patients with 
AGA were examined by immunohistochemistry before and 
after treatment, which lasted for 3 months and included 3 
PRP sessions (once per month) and topical application of 
minoxidil 2 % lotion twice daily. 
Results. It was found that AGA is accompanied by inflam-
matory perifollicular infiltration by T-lymphocytes CD3+, 
CD4+ and CD8+, macrophages (CD68+); imbalance of 
growth polypeptides VEGF, TGF-β1, EGFR; accumulation 
of oxidative stress enzymes eNOS and iNOS; accumulation 
of pathological fraction of Collagen IV. The use of plate-
let-rich plasma in combination with topical 2 % minoxidil 
as AGA therapy leads to the normalization of immunohis-
tochemical parameters of the skin, which indicates the pos-
sibility of its use for long-term therapeutic effect. 
Conclusions. This study supplemented the understanding 
of the pathogenesis of AGA and serves as the basis for im-
proving treatment regimens for this pathology. But more 
research is required to further study the pathomorphology 
of androgenetic alopecia and to standardize the technique 
of using platelet-rich plasma in patients with this disease.
Keywords: androgenetic alopecia, female patients, plate-
let-rich plasma, topical minoxidil, immunohistochemical 
examination of skin biopsies.
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Tissue fragments were performed by standard histological 
methods, stained with hematoxylin and eosin.
IHC study was conducted on the basis of the laboratory of 
the Department of Pathological Anatomy of the Kharkiv Med-
ical Academy of Postgraduate Education using antibodies and 
imaging system of Thermo scientific, Germany. The qualitative 
composition of the inflammatory infiltrate was studied using 
monoclonal antibodies (MCAB) to CD 3, CD 4 Clone 4B12, 
CD8 (SP16) (different fractions of T lymphocytes, Ready-to-
Use), CD68 KP1 (macrophage marker, Ready-to-Use). To detect 
oxidative disorders, the expression of nitric oxide metabolism 
markers was investigated: endothelial nitric oxide synthase 
(eNOS, Nitric Oxide Synthase, Rabbit Polyclonal Antibody at a 
dilution of 1:50) and inducible synthase of Nitric oxide (iNOS), 
Rabbit Polyclonal Antibody at a dilution of 1:100). The nature of 
angiogenesis was assessed by the expression of vascular endo-
thelial growth factor (VEGF (VG1)). Epidermal growth factor 
expression was determined using EGFR Polyclonal Antibody 
(titer 1:100). As a factor in the induction of the inflammatory 
process, transforming growth factor (PCAT to TGF-β1 (V) 
Antibody, Ready-to-Use) was studied. Bcl 2 (124), Ready-to-Use, 
was used as a marker of apoptosis. Collagen IV (CIV22) with a 
titer of 1:50 was detected in the areas of fibrosis.
Unmasking heat treatment was performed by boiling the 
sections in citrate buffer (pH 6.0–7.0). UltraVision Quanto 
Detection Systems HRP Polymer (Thermo scientific, Germany) 
was used to visualize the primary antibodies. DAB (diamino-
benzidine) was used as the chromogen.
The results were calculated using the Avtandilov eyepiece 
in 10 randomly selected fields of view at a magnification of 
×400 [8]. The IHC label was evaluated on two parameters: the 
degree of distribution and intensity of staining, taking into ac-
count the severity of the reaction and its location.
The degree of spread of the label was taken into account by 
the percentage of positively stained brown organelle cells from 
the total number of cells in the field of view. To assess the degree 
of color intensity used a semi-quantitative scale: negative (0) was 
the reaction in the absence of staining of specific cell structures, 
weak positive (1+) was the reaction with weak or focal staining 
from 0 to 30 % of cells, moderate positive (2+) – when sufficient 
or focal staining of 30–60 % of cells, pronounced or diffuse (3+) 
was considered a reaction when staining 60–90 % of cells.
The complex of morphological studies was performed on 
a Primo Star microscope (Carl Zeiss) using the program Axio-
Cam (ERc 5 s).
Statistical processing of the obtained results was carried out 
using the Statistica 6.0 software. When interpreting the signifi-
cance of the difference in the results, the Student’s test was used, 
the critical value of the significance level was considered p<0.05.
3. Results
In all cases of the main study group before treatment, the 
dermis was thinned with signs of hair loss. Hair of various 
diameters and vellus hair grew from miniaturized follicles. Be-
tween the preserved hair follicles, in the area of empty hair bags 
in the area of the upper part of the hair follicles, areas of dermal 
fibrosis were found, they consisted of concentrically located 
bundles of connective tissue fibers. The number of sebaceous 
glands was increased compared to the skin of healthy women. 
In 28 cases out of 30 perivascularly, perifollicularly and between 
the acinuses of the sebaceous glands, we observed lympho-his-
tiocytic infiltrate of varying severity.
About ¾ of inflammatory infiltrate cells in the main group 
were represented by CD3+ T-lymphocytes; 40 % of them were 
CD4+ T-lymphocytes, and they were observed mainly in the 
perifollicular area outside the foci of fibrosis, between the aci-
nuses of the sebaceous and sweat glands. CD8+ T lymphocytes 
accounted for one third of all T lymphocytes and were found in 
the connective tissue layers and perivascularly in the dermis and 
hypodermis. 11 % of inflammatory infiltrate cells accounted for 
CD68+ macrophages, which were located mainly in the fibrosis 
fields and deeper parts of the dermis.
Expression of eNOS in the skin of healthy women was found 
only in single macrophages, fibroblasts and vascular endothe-
liocytes, while in the main group it was observed in numerous 
macrophages, fibroblasts, endothelial insole and vascular layer, 
as well as in epitheliocytes. Inducible nitric oxide synthase 
(iNOS) was not determined in the control group, in biopsies 
with AGA it was expressed in macrophages, vascular endothe-
lial cells, single epitheliocytes of follicles and sebaceous glands 
and in fibroblasts of the perifollicular fibrosis zone.
The content of VEGF, as well as collagen type 4 was reduced: 
the reaction with vascular growth factor in the vascular endo-
thelium was weak (1+), especially in areas of concentric fibrosis 
with depleted vascularization. The basement membranes of 
the epidermis, glands, hair follicles and blood vessels lost spe-
cialized type 4 collagen, and, conversely, its accumulation was 
recorded in atypical areas of perifollicular fibrosis.
The content of TGF-β1 and EGFR was increased in compari-
son with the control group. A pronounced positive reaction (3+) 
with PCAB to transforming growth factor was observed above 
all in numerous macrophages around the vessels and among the 
connective tissue strands of fibrosis. Epidermal growth factor 
marked both the thinned epidermis and the cells of the epithe-
lial sheaths of the hair.
The distribution of the antiapoptotic protein Bcl-2 was mod-
erate and, more often, weakly expressed (1+), its expression was 
detected in inflammatory infiltrate cells and correlated with 
increased activity of nitric oxide synthase, especially inducible.
After treating patients with platelet-rich plasma in combina-
tion with minoxidil 2 % lotion, we observed the following. The 
thickness of the dermis ranged from 1.19 to 1.58 mm and aver-
aged 1.40 mm, which was 0.04 mm less compared to the control 
group, and 0.3 mm more than before treatment (p≤0.05). Hair of 
the same diameter grew from follicles of normal size. The hair 
follicles of the hair follicles, as in the control group, were evenly 
distributed in the reticular layer of the dermis and in the hypo-
dermis. The reticular layer differed in a network of connective 
tissue fibers with a free location of sebaceous and sweat glands, 
as observed in the skin of healthy women. In all 30 cases, mainly 
perivascular, diffuse lympho-histiocytic infiltrate occurred, 
perifollicular and between the acinuses of the sebaceous glands’ 
infiltration was not observed.
CD3+T-lymphocytes accounted for 17.6 % of the total pool 
of the inflammatory component, 6.8 % and 5.9 % were CD4+ 
and CD8+ T-lymphocytes, respectively. 3.4 % of inflammatory 
infiltrate cells accounted for CD68+ macrophages, which were 
located mainly around the vessels and deeper parts of the der-
mis (Table 1).
The expression of nitrogen synthases of eNOS and iNOS in 
the skin of patients of the main group after treatment, as in the 
control group, was unidirectional, was detected at the level of 
1+ mainly in the cells of the inner insole, single macrophages, 
fibroblasts.
The content at the location of growth peptides was also 
close to the indicators of the control group: vascular-endothelial 
growth factor VEGF, transforming factor TGF-β1 marked the 
endothelium of the numerous capillaries of the reticular layer 
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(2+ and 1+, respectively). Epidermal growth factor EGFR was 
determined as a weak reaction (1+) in the epidermis and epithe-
lial cells of the vaginal hair.
Table 1
The ratio of immunocompetent cells in the dermis infiltrate in 






before treatment after treatment
CD 3 14.2±7.8 % 76.6±7.7 % 17.6±6.9 %
CD 4 3.3±4.0 % 40.0±1.05 % 6.8±4.6 %
CD8 4.6±4.7 % 26.7±8.1 % 5.9±4.3 %
CD 68 2.1±3.2 % 11.0±5.7 % 3.4±3.3 %*
Note: * – р≤0.05
Type 4 collagen was found only in the basement membranes 
of the epidermis, sebaceous and sweat glands, hair follicles and 
blood vessels. The expression of the antiapoptotic protein Bcl-2 
was moderate (2+), was determined in single inflammatory 
infiltrate cells, both in cases after treatment and in the control 
group (Table 2).
Table 2
Expression of IGH markers in AGA by study groups
IHC marker Control group n=20
Main group n=30
Before treatment After treatment
eNOS 1+ 3+ 1+
iNOS – 3+ –
VEGF 3+ 1+ 2+
EGFR 1+ 3+ 1+
TGF-β1 1+ 3+ 1+
Bcl 2 2+ 1+ 2+
Collagen IV 1+ 3+ 1+
4. Discussion
Diagnosis of AGA includes assessment of clinical mani-
festations of the disease, detection of pathology of the thyroid 
gland, pituitary gland, ovarian and adrenal gland diseases, 
liver, without detailed consideration of the molecular and 
biological characteristics of the skin of patients. It is known 
that the main number of regulatory proteins and growth 
factors, such as VEGF, TGF-β1, EGFR, is synthesized in the 
dermal papilla. Fibroblasts, epitheliocytes, endothelial cells 
of its capillary in the inf lammatory process, which we found 
in 93.3 % of observations of the main study group, as well as 
T-lymphocytes and macrophages of inf lammatory infiltrate 
lose the ability to fully produce these control substances. In 
turn, the matrix of the hair follicle and the adjacent dermis 
begin to accumulate the products of enzymatic decomposi-
tion of nitric oxide eNOS and iNOS, which can be regarded 
as a manifestation of oxidative stress [9]. Type 4 collagen 
deposition is observed in the connective tissue fibers of the 
dermis and bundles of concentric perifollicular fibrosis. At 
each of these stages’ apoptosis-mediated cell death has been 
detected.
The search for the most effective protocols for the 
treatment of AGA continues. Techniques with pronounced 
antioxidant, anti-inf lammatory and immunocorrective ef-
fects are discussed as promising areas of etiopathogenetic 
therapy of AGA. The use of finasteride, minoxidil, other 
topical and oral drugs, instrumental methods does not lead 
to a lasting effect [10]. The use of platelet-enriched plasma 
in combination with topical minoxidil is quite common in 
trichological clinics around the world, so we tried to find the 
immunomophological basis for the treatment of AGA with 
this combination.
Study limitations. In accordance with the limitations of 
this study, the results can be determined as preliminary and 
requires further research to standardize the PRP method for 
female patients with AGA.
Prospects for further research. For further detailed anal-
ysis, we plan to continue this study with a larger number of 
patients.
5. Conclusions
The results of the IHC reaction in the dermis of patients 
with AGA in the form of increased expression of nitric oxide 
synthase eNOS and iNOS indicate the presence of oxidative dis-
orders with an imbalance of immunocompetent T-lymphocytes 
CD3+, CD4+ and CD8+, macrophages (CD68+) and growth fac-
tors VEGF, TGF-β1, EGFR. The basis of progressive alopecia is 
the production by fibroblasts of hair follicles of the pathological 
fraction of collagen type 4 with the development of perifollic-
ular fibrosis and increased apoptosis. The use of platelet-rich 
plasma in combination with 2 % minoxidil as therapy for AGA 
leads to the restoration of functional skin morphology, which is 
manifested by changes in the expression of IHC markers, with 
levels close to normal skin. Further study of the signalling path-
ways involved in hair growth should open up new medicinal 
targets in the future.
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